The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical assessment of PM21-particle expanded natural killer cells for ovarian cancer treatment.
 
Jeremiah Oyer
Stock and Other Ownership Interests - Cyto-Sen Therapeutics
Research Funding - Cyto-Sen Therapeutics
Patents, Royalties, Other Intellectual Property - Cyto-Sen Therapeutics, Inc.
Other Relationship - Cyto-Sen Therapeutics
 
Sarah B. Gitto
No Relationships to Disclose
 
Deborah Altomare
Stock and Other Ownership Interests - Cyto-Sen Therapeutics
Patents, Royalties, Other Intellectual Property - Cyto-Sen Therapeutics, Inc.
Other Relationship - Cyto-Sen Therapeutics
 
Dean A. Lee
Leadership - Cyto-Sen Therapeutics
Stock and Other Ownership Interests - Cyto-Sen Therapeutics
Patents, Royalties, Other Intellectual Property - Cyto-Sen Therapeutics, Inc.
Other Relationship - Cyto-Sen Therapeutics
 
Alicja Copik
Stock and Other Ownership Interests - Cyto-Sen Therapeutics; Cyto-Sen Therapeutics (I)
Research Funding - Cyto-Sen Therapeutics
Patents, Royalties, Other Intellectual Property - Cyto-Sen Therapeutics, Inc.; Cyto-Sen Therapeutics, Inc. (I)
Other Relationship - Cyto-Sen Therapeutics; Cyto-Sen Therapeutics (I)